HCA Healthcare, Inc. financial data

Symbol
HCA on NYSE
Industry
Services-General Medical & Surgical Hospitals, NEC
Location
One Park Plz, Nashville, TN
Fiscal year end
December 31
Former names
HCA Holdings, Inc. (to 5/5/2017), HCA INC/TN (to 11/24/2010), HCA THE HEALTHCARE CO (to 5/21/2001), HCA-THE HEALTHCARE CO (to 2/14/2001), COLUMBIA HCA HEALTHCARE CORP (to 5/19/2000), COLUMBIA HCA HEALTHCARE CORP/ (to 2/16/2000), COLUMBIA HEALTHCARE CORP (to 3/1/1994)
Latest financial report
10-Q - Q2 2024 - Jul 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 114 % -12%
Quick Ratio 14.8 % -24%
Return On Equity 570 %
Return On Assets 10.2 % -7.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 258M shares -5.12%
Common Stock, Shares, Outstanding 259M shares -5.02%
Entity Public Float 61.1B USD +69%
Weighted Average Number of Shares Outstanding, Basic 261M shares -4.86%
Weighted Average Number of Shares Outstanding, Diluted 264M shares -5.08%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 68.3B USD +10.4%
General and Administrative Expense 337M USD +9.06%
Costs and Expenses 59.9B USD +12.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 8.46B USD -3.18%
Income Tax Expense (Benefit) 1.83B USD +2.34%
Net Income (Loss) Attributable to Parent 5.74B USD -0.57%
Earnings Per Share, Basic 21.6 USD/shares +5.11%
Earnings Per Share, Diluted 21.3 USD/shares +5.14%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 831M USD -3.6%
Accounts Receivable, after Allowance for Credit Loss, Current 10.2B USD +17.5%
Inventory, Net 1.8B USD -12.2%
Other Assets, Current 2.3B USD +1.77%
Assets, Current 15.2B USD +9.25%
Property, Plant and Equipment, Net 28.6B USD +7.49%
Operating Lease, Right-of-Use Asset 2.18B USD +3.27%
Other Assets, Noncurrent 240M USD +22.4%
Assets 57.4B USD +7.06%
Accounts Payable, Current 4.03B USD +5.39%
Liabilities, Current 14.3B USD +23.9%
Operating Lease, Liability, Noncurrent 1.89B USD +4.87%
Accumulated Other Comprehensive Income (Loss), Net of Tax -433M USD +5.04%
Retained Earnings (Accumulated Deficit) -1.17B USD +36.8%
Stockholders' Equity Attributable to Parent -1.6B USD +30.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.34B USD +190%
Liabilities and Equity 57.4B USD +7.06%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.47B USD +36.9%
Net Cash Provided by (Used in) Financing Activities -1.22B USD -67.7%
Net Cash Provided by (Used in) Investing Activities -903M USD +21.5%
Common Stock, Shares Authorized 1.8B shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 349M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 831M USD -3.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 538M USD -6.27%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.27 pure +12%
Operating Lease, Liability 2.27B USD +7.09%
Payments to Acquire Property, Plant, and Equipment 1.12B USD -6.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 5.76B USD -1.18%
Lessee, Operating Lease, Liability, to be Paid 3.24B USD +17.9%
Property, Plant and Equipment, Gross 60.6B USD +6.99%
Operating Lease, Liability, Current 363M USD -0.28%
Lessee, Operating Lease, Liability, to be Paid, Year Two 394M USD +3.68%
Lessee, Operating Lease, Liability, to be Paid, Year One 452M USD +3.67%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +22.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 976M USD +54.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 340M USD +6.25%
Unrecognized Tax Benefits 639M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 288M USD +7.06%
Depreciation, Depletion and Amortization 3.17B USD +5.1%
Deferred Tax Assets, Net of Valuation Allowance 2.22B USD +1.56%
Interest Expense 1.99B USD +6.92%